Exagen Inc. (XGN)

Last Closing Price: 7.58 (2026-09-04)

Consolidated Net Income/Loss (Quarterly)

Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.

Exagen Inc. (XGN) had Consolidated Net Income/Loss of $-3.20M for the most recently reported fiscal quarter, ending 2026-06-30.

Figures for fiscal quarter ending 2026-06-30
Income Statement Financials
$19.94M
$-3.20M
$7.72M
$12.22M
$21.66M
$-1.72M
$-1.47M
$-3.20M
$-3.20M
$-3.20M
$-3.20M
Consolidated Net Income/Loss
$-3.20M
$-3.20M
$-1.72M
$-0.78M
24.16M
24.16M
$-0.13
$-0.13
Balance Sheet Financials
$42.86M
$6.57M
$9.08M
$51.94M
$13.46M
$23.94M
$26.26M
$39.72M
$12.22M
$12.22M
$12.22M
24.19M
Cash Flow Statement Financials
$-6.43M
$-0.77M
$-0.43M
$32.42M
$24.79M
$-7.63M
$1.64M
--
--
Fundamental Metrics & Ratios
3.18
--
--
0.66
2.09
61.27%
-8.64%
-8.64%
--
-16.03%
-16.03%
$-7.20M
--
--
--
0.38
--
1.61
56.00
-26.16%
-26.16%
-6.15%
-8.84%
$0.50
$-0.30
$-0.27